scholarly journals Drug‐induced linear immunoglobulin A bullous dermatosis: A French retrospective pharmacovigilance study of 69 cases

2019 ◽  
Vol 85 (3) ◽  
pp. 570-579 ◽  
Author(s):  
Bethsabée Garel ◽  
Saskia Ingen‐Housz‐Oro ◽  
Daniele Afriat ◽  
Catherine Prost‐Squarcioni ◽  
Florence Tétart ◽  
...  
Keyword(s):  
Immunoglobulin A ◽  
Drug Induced ◽  
Bullous Dermatosis

Drug-Induced Linear Immunoglobulin-A Bullous Dermatosis

1998 ◽  
Vol 16 (3) ◽  
pp. 389-391 ◽  
Author(s):  
Michael Camilleri ◽  
Joseph L. Pace
Keyword(s):  
Immunoglobulin A ◽  
Drug Induced ◽  
Bullous Dermatosis

Linear Immunoglobulin a Bullous Dermatosis Induced by Gemcitabine

2001 ◽  
Vol 35 (7-8) ◽  
pp. 891-893 ◽  
Author(s):  
Jesús del Pozo ◽  
Walter Martínez ◽  
María T Yebra-Pimentel ◽  
Manuel Almagro ◽  
Carmen Peña-Penabad ◽  
...  
Keyword(s):  
Immunoglobulin A ◽  
Topical Steroid ◽  
Direct Immunofluorescence ◽  
Cutaneous Lesions ◽  
Drug Induced ◽  
Cutaneous Eruption ◽  
First Case ◽  
Bullous Dermatosis ◽  
Relationship Of ◽  
The Relationship

OBJECTIVE: To report a case of linear immunoglobulin (Ig) A bullous dermatosis (LABD) induced by gemcitabine. CASE SUMMARY: A 59-year-old man was diagnosed with squamous-cell carcinoma of the lung in T4N2M0 stage and treated with cisplatin, vinorelbine, and gemcitabine. Twenty-four hours after the administration of gemcitabine, a symmetric, bullous, herpetiform eruption appeared on his trunk and upper limbs. Histopathologic examination and direct immunofluorescence test were consistent with IgA bullous dermatosis. Cutaneous lesions resolved two weeks after the drug was withdrawn and topical steroid treatment was instituted. DISCUSSION: Drug-induced LABD is a variant of classic or idiopathic LABD. Vancomycin is the most frequently implicated drug, but other agents have been reported to cause LABD. According to the Naranjo probability scale, the relationship of gemcitabine treatment with cutaneous eruption in our patient is possible. CONCLUSIONS: We report the first case of gemcitabine-induced LABD. Clinicians should monitor patients receiving this drug for signs of LABD.

scholarly journals Concurrent Drug-Induced Linear Immunoglobulin A Dermatosis and Immunoglobulin A Nephropathy

2015 ◽  
Vol 27 (3) ◽  
pp. 315 ◽  
Author(s):  
Ji Seok Kim ◽  
Misoo Choi ◽  
Chan Hee Nam ◽  
Jee Young Kim ◽  
Byung Cheol Park ◽  
...  
Keyword(s):  
Immunoglobulin A ◽  
Immunoglobulin A Nephropathy ◽  
Drug Induced

scholarly journals Linear Immunoglobulin A Bullous Dermatosis: Need for an Agreement on Diagnostic Criteria

Dermatology ◽  
2013 ◽  
Vol 226 (4) ◽  
pp. 329-332 ◽  
Author(s):  
Emiliano Antiga ◽  
Marzia Caproni ◽  
Paolo Fabbri
Keyword(s):  
Diagnostic Criteria ◽  
Immunoglobulin A ◽  
Bullous Dermatosis

scholarly journals Vancomycin-induced linear Immunoglobulin A bullous dermatosis

2019 ◽  
Vol 12 (12) ◽  
pp. e233281 ◽  
Author(s):  
Htay Phyu ◽  
Takaaki Kobayashi ◽  
Prerna Rastogi ◽  
Christine Cho
Keyword(s):  
Immunoglobulin A ◽  
Bullous Dermatosis

Drug-induced linear immunoglobulin a bullous disease that clinically mimics toxic epidermal necrolysis

2000 ◽  
Vol 021 (3) ◽  
pp. 246-247 ◽  
Author(s):  
J. P. Gowar ◽  
Mona Z. Mofid ◽  
Constantino Z. Costarangos ◽  
Benjamin Z. Bernstein ◽  
Lesley Z. Wong ◽  
...  
Keyword(s):  
Toxic Epidermal Necrolysis ◽  
Immunoglobulin A ◽  
Drug Induced ◽  
Bullous Disease
Sign in / Sign up

Export Citation Format

Share Document